Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mami Yasumoto"'
Autor:
Shogo Shinohara, Shinji Takebayashi, Kiyomi Hamaguchi, Tetsuhiko Michida, Yota Tobe, Tadashi Ikenaga, Mami Yasumoto, Ayami Hamamoto, Toshiyuki Imagumbai, Takamasa Mitsuyoshi, Ryo Ashida, Takahiro Iwai, Shun Okabayashi
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 15 (2021)
Background: Concurrent chemoradiotherapy (CCRT) with tri-weekly high-dose cisplatin (HDC) is considered the standard regimen. However, due to significant toxicity, various weekly low-dose schedules have been increasingly used. We investigated the tol
Externí odkaz:
https://doaj.org/article/7c652ffcb8b1419ca2c4bc602d5702e7
Autor:
Tomoko Yamamoto, Shogo Shinohara, Keishi Ueda, Mami Yasumoto, Ayami Hamamoto, Yota Tobe, Tadashi Ikenaga, Tetsuhiko Michida, Hiroshi Yamazaki, Kiyomi Hamaguchi, Keizo Fujiwara, Yasushi Naito, Ryutaro Seo, Machi Yanai, Yoko Asaka
Publikováno v:
Nihon Kikan Shokudoka Gakkai Kaiho. 73:363-368
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd6981be1c8ec79d5d803e58aa265efc
https://doi.org/10.2468/jbes.73.363
https://doi.org/10.2468/jbes.73.363
Autor:
Kiyomi Hamaguchi, Shogo Shinohara, Tetsuhiko Michida, Mami Yasumoto, Ayami Hamamoto, Tomoko Yamamoto, Keishi Ueda, Eugene Nakamura
Publikováno v:
Auris Nasus Larynx.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::694dd6522190bd19f5784f799ef34a33
https://doi.org/10.1016/j.anl.2023.04.005
https://doi.org/10.1016/j.anl.2023.04.005
Autor:
Tetsuhiko Michida, Shogo Shinohara, Ayami Hamamoto, Mami Yasumoto, Yota Tobe, Tadashi Ikenaga, Keisuke Mizuno, Koji Saida, Kiyomi Hamaguchi, Shinji Takebayashi, Hiroshi Yamazaki, Keizo Fujiwara, Yasushi Naito
Publikováno v:
Practica Oto-Rhino-Laryngologica. 115:771-778
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4d491f0be25bfb94e979cc523673af7
https://doi.org/10.5631/jibirin.115.771
https://doi.org/10.5631/jibirin.115.771
Autor:
Tadashi Ikenaga, Shogo Shinohara, Shinji Takebayashi, Kiyomi Hamaguchi, Tetsuhiko Michida, Yota Tobe, Ayami Hamamoto, Mami Yasumoto
Publikováno v:
Practica Oto-Rhino-Laryngologica. 115:679-684
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b26cf2aa5f9cd5995b8398c06a4d3c5b
https://doi.org/10.5631/jibirin.115.679
https://doi.org/10.5631/jibirin.115.679
Autor:
Yota Tobe, Shogo Shinohara, Kiyomi Hamaguchi, Shinji Takebayashi, Tetsuhiko Michida, Tadashi Ikenaga, Ayami Hamamoto, Mami Yasumoto
Publikováno v:
Practica Oto-Rhino-Laryngologica. 115:307-314
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a18051cf855db2636408afb3330b71a3
https://doi.org/10.5631/jibirin.115.307
https://doi.org/10.5631/jibirin.115.307
Autor:
Ayami Hamamoto, Yota Tobe, Kiyomi Hamaguchi, Tetsuhiko Michida, Shogo Shinohara, Shinji Takebayashi, Mami Yasumoto, Tadashi Ikenaga
Publikováno v:
Toukeibu Gan. 47:311-315
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eabada79af08a36b1f278bd8bd9ac316
https://doi.org/10.5981/jjhnc.47.311
https://doi.org/10.5981/jjhnc.47.311
Autor:
Tadashi Ikenaga, Keizo Fujiwara, Mami Yasumoto, Ayami Hamamoto, Shinji Takebayashi, Shogo Shinohara, Yota Tobe, Tetsuhiko Michida, Daisuke Yamashita, Shigeo Hara, Kiyomi Hamaguchi, Yasushi Naito, Hiroshi Yamazaki
Publikováno v:
Practica Oto-Rhino-Laryngologica. 114:951-955
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2af1081a389002ec5660bd6a01e9670a
https://doi.org/10.5631/jibirin.114.951
https://doi.org/10.5631/jibirin.114.951
Autor:
Takamasa Mitsuyoshi, Tadashi Ikenaga, Shogo Shinohara, Mami Yasumoto, Yota Tobe, Ayami Hamamoto, Takahiro Iwai, Toshiyuki Imagumbai, Ryo Ashida, Shun Okabayashi, Tetsuhiko Michida, Shinji Takebayashi, Kiyomi Hamaguchi
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 15 (2021)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights. Oncology
Background: Concurrent chemoradiotherapy (CCRT) with tri-weekly high-dose cisplatin (HDC) is considered the standard regimen. However, due to significant toxicity, various weekly low-dose schedules have been increasingly used. We investigated the tol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::373b695b7d3e3a5818f87fe1222bb22b
https://doi.org/10.1177/11795549211048417
https://doi.org/10.1177/11795549211048417